Use of alpha-MSH and EPO for preventing or treating ischemic conditions

Details for Australian Patent Application No. 2001254625 (hide)

International Classifications

Event Publications

27 October 2005 Assignment before Grant

Selskabet af 20.02.2002 ApS The application has been assigned to Action Pharma A/S

27 October 2005 Change of Name(s) of Applicant(s), Section 104

Action Pharma APS The name of the applicant has been changed to Selskabet af 20.02.2002ApS

2 February 2006 Application Accepted

Published as AU-B-2001254625

27 April 2006 Amendment Made

The nature of the amendment is: Amend the name of the co-inventor from Bjerke, Thorbjorn to Bjerke, Torbjorn

1 June 2006 Standard Patent Sealed

27 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.